期刊文献+

静脉盐水负荷试验在原发性醛固酮增多症诊断中的价值 被引量:6

Evaluation of intravenous saline load test in diagnosis of primary aldosteronism
原文传递
导出
摘要 目的探讨静脉盐水负荷试验在原发性醛固酮增多症诊断中的应用价值。方法选择2006-2010年临床诊断为原发性醛固酮增多症的患者47例,行静脉盐水负荷试验并同时检测其血、尿醛固酮及血钾等生化指标。以30例原发性高血压患者作为对照组。结果与对照组比较,原发性醛固酮增多症患者静脉盐水负荷试验前、后血醛固酮水平、24h尿醛固酮排量显著升高,血钾水平明显下降;原发性醛固酮增多症患者血醛固酮的抑制率[(13.3±5.6)%]和受抑制患者的比例(4.3%)明显低于对照组[分别为(78.0±12.5)%和(93.3%)],该试验对原发性醛固酮增多症诊断的敏感性和特异性分别为95.7%(45/47)和93.3%(28/30)。结论静脉盐水负荷试验是一项安全可靠的原发性醛固酮增多症确诊方法,其敏感性和特异性均较高。 Objective To investigate the value of intravenous (i. v. ) saline load test in the diagnosis of primary aldosteronism. Methods From year 2006 to 2010, 47 patients clinically diagnosed with primary aldosteronism were performed i. v. saline load test, plasma and urinary aldosterone, and serum potassium were examined at the same time. 30 patients with essential hypertension were served as controls. Results Compared with the control group, patients with primary aldosteronism had higher plasma and urinary aldosterone, lower serum potassium. The inhibition ratio ( 13.3± 5.6)% and the proportion of patients restrained (4.3 % ) after i. v. saline load test in primary aldosteronism group were lower than those in control group [ (78.0±12.5) % and (93.3%), respectively]. The sensitivity and specificity of i.v. saline load test for primary aldosteronism were 95.7% (45/47) and 93.3% (28/30). Conclusions The i.v. saline load test is a safe and reliable confirmatory test for the diagnosis of primary aldosteronism with a high sensitivity and specificity.
出处 《中国预防医学杂志》 CAS 2012年第7期489-491,共3页 Chinese Preventive Medicine
关键词 原发性醛固酮增多症 静脉盐水负荷试验 敏感性 特异性 Primary aldosteronism I.v. saline load test Sensitivity Specificity
  • 相关文献

参考文献10

二级参考文献37

共引文献47

同被引文献59

  • 1陈绍行,杜月凌,张瑾,龚艳春,胡亚蓉,初少莉,何清波,宋艳艳,朱鼎良.在高血压患者中筛选原发性醛固酮增多症国人血浆醛固酮/肾素活性比值标准的探讨[J].中华心血管病杂志,2006,34(10):868-872. 被引量:48
  • 2张炜,汤正义,吴景程,王卫庆,宁光.静脉盐水负荷试验在原发性醛固酮增多症诊断中的应用[J].上海交通大学学报(医学版),2007,27(6):703-705. 被引量:22
  • 3苏树娟,钟力平,周峥.输液毫升与滴数换算关系的再探讨[J].护理学杂志(综合版),2007,22(4):52-53. 被引量:6
  • 4殷磊.护理学基础[M].北京:人民卫生出版社,2005.100.
  • 5Rossi G P, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients[J]. J AmCollCardiol,2006,48(11):2293- 2300.
  • 6Born Frontsberg E, Reincke M, Rump I. C, el al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism results of the German ('omm's Refistry[J]. J Clin Endocrinol Metab, 2009, 94 (4); 1125-1130.
  • 7符春晖,严华.陆永光.等.原发性高血压病患者肾素-血管紧张素-醛同酮系统活性的影响冈素[J].中华实州诊断与治疗杂志,2011,25(7):633-636.
  • 8Funder J W, Carey R M, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline [J]. Clin Endoerinol Metab,2008,93(9):3266-3281.
  • 9Niizuma S, Nakahama H, Kamide K, et al. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine[J]. Clin Exp Hypertens,2008,30(7) :640-647.
  • 10Tzanela M, Effremidis G, Vassiliadi D, et al. The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal massesI-J]. Endocrine,2007,32(2) : 136 142.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部